Complex Lesion PCI

Preventive PCI versus culprit lesion stenting during primary PCI in acute STEMI: a systematic review and meta-analysis

AIM The benefit of preventive percutaneous coronary intervention (PCI) in ST elevation myocardial infarction (STEMI) has been shown in randomised trials. However, all the randomised trials are underpowered to detect benefit in cardiac death. We aim to systematically review evidence on the cardiac mortality benefit of preventive PCI in patients presenting with acute STEMI in randomised patient p...

Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.

BACKGROUND Optimal upfront dual antiplatelet therapy (DAPT) duration after complex percutaneous coronary intervention (PCI) with drug-eluting stents (DES) remains unclear. OBJECTIVES This study investigated the efficacy and safety of long-term (≥12 months) versus short-term (3 or 6 months) DAPT with aspirin and clopidogrel according to PCI complexity. METHODS The authors pooled patient-leve...

Optimum guidance of complex PCI by coronary pressure measurement.

Correspondence to: Dr Nico H J Pijls, Catharina Hospital, PO Box 1350, 5602 ZA Eindhoven, the Netherlands; cardiologie. [email protected] _________________________ I n 1993, 1450 coronary interventions were performed in the Catharina Hospital in Eindhoven, the Netherlands. At that time, due to financial restraints, stents were not available. After two years of follow up, the reintervention r...

PCI Interrupt Controller for Industry Standard PCI-ISA Bus Architecture using PCI-to-PCI Bridge Technology

The demand for more Peripheral Computer Interconnect (PCI) device configurations beyond the limit set in the PCI local bus specification has prompted the development of several PCI-PCI bridge solutions. This paper describes a new PCI Industrial Computer Manufacturers Group (PICMG) PCI-ISA bus architecture implementation using Digital Equipment Corporation PCI-PCI bridge technology. Layered PCI ...

Compounding the Bleeding Reduction Effects of Transradial PCI and Bivalirudin in a High-Risk Patient Undergoing Complex PCI